» Articles » PMID: 27386546

Fundamentals of Cancer Metabolism

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2016 Jul 8
PMID 27386546
Citations 1409
Authors
Affiliations
Soon will be listed here.
Abstract

Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.

Citing Articles

Glucose Metabolism and Tumor Microenvironment: Mechanistic Insights and Therapeutic Implications.

Andryszkiewicz W, Gasiorowska J, Kubler M, Kublinska K, Palkiewicz A, Wiatkowski A Int J Mol Sci. 2025; 26(5).

PMID: 40076506 PMC: 11900028. DOI: 10.3390/ijms26051879.


L- and D-Lactate: unveiling their hidden functions in disease and health.

Li J, Ma P, Liu Z, Xie J Cell Commun Signal. 2025; 23(1):134.

PMID: 40075490 PMC: 11905701. DOI: 10.1186/s12964-025-02132-z.


Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair.

Chiang J, Shang Z, Rosales T, Cai L, Chen W, Cai F Sci Adv. 2025; 11(11):eadt1241.

PMID: 40073141 PMC: 11900879. DOI: 10.1126/sciadv.adt1241.


HOTAIR Participation in Glycolysis and Glutaminolysis Through Lactate and Glutamate Production in Colorectal Cancer.

Flores-Garcia L, Garcia-Castillo V, Perez-Toledo E, Trujano-Camacho S, Millan-Catalan O, Perez-Yepez E Cells. 2025; 14(5).

PMID: 40072116 PMC: 11898799. DOI: 10.3390/cells14050388.


Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy.

Wan Y, Li G, Cui G, Duan S, Chang S Mol Cancer. 2025; 24(1):74.

PMID: 40069775 PMC: 11895238. DOI: 10.1186/s12943-025-02263-4.


References
1.
Tomimoto A, Endo H, Sugiyama M, Fujisawa T, Hosono K, Takahashi H . Metformin suppresses intestinal polyp growth in ApcMin/+ mice. Cancer Sci. 2008; 99(11):2136-41. PMC: 11159964. DOI: 10.1111/j.1349-7006.2008.00933.x. View

2.
Schug Z, Peck B, Jones D, Zhang Q, Grosskurth S, Alam I . Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell. 2015; 27(1):57-71. PMC: 4297291. DOI: 10.1016/j.ccell.2014.12.002. View

3.
Stine Z, Walton Z, Altman B, Hsieh A, Dang C . MYC, Metabolism, and Cancer. Cancer Discov. 2015; 5(10):1024-39. PMC: 4592441. DOI: 10.1158/2159-8290.CD-15-0507. View

4.
Lussey-Lepoutre C, Bellucci A, Morin A, Buffet A, Amar L, Janin M . In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma. Clin Cancer Res. 2015; 22(5):1120-9. DOI: 10.1158/1078-0432.CCR-15-1576. View

5.
Herranz D, Ambesi-Impiombato A, Sudderth J, Sanchez-Martin M, Belver L, Tosello V . Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med. 2015; 21(10):1182-9. PMC: 4598309. DOI: 10.1038/nm.3955. View